tiprankstipranks
Moderna’s RSV Vaccine Nears EU Approval
PremiumCompany AnnouncementsModerna’s RSV Vaccine Nears EU Approval
23d ago
Moderna announces positive CHMP opinion for marketing authorization of mRESVIA
PremiumThe Fly
Moderna announces positive CHMP opinion for marketing authorization of mRESVIA
23d ago
Carisma Therapeutics nominates first candidate under collaboration with Moderna
PremiumThe Fly
Carisma Therapeutics nominates first candidate under collaboration with Moderna
24d ago
Moderna Season 2 RSV data on lower end of expectations, says Jefferies
PremiumThe FlyModerna Season 2 RSV data on lower end of expectations, says Jefferies
25d ago
Moderna falls 6% ato $130.03 after RSV vaccine data
PremiumThe Fly
Moderna falls 6% ato $130.03 after RSV vaccine data
25d ago
Moderna falls after RSV vaccine shows 50% efficacy after 18 months
PremiumThe Fly
Moderna falls after RSV vaccine shows 50% efficacy after 18 months
25d ago
Moderna announces Phase 3 trial of mRNA-1283 met primary efficacy endpoint
PremiumThe FlyModerna announces Phase 3 trial of mRNA-1283 met primary efficacy endpoint
1M ago
SPY ETF Update, 6/13/2024  
PremiumMarket News
SPY ETF Update, 6/13/2024  
1M ago
Moderna price target raised to $179 from $163 at Oppenheimer
PremiumThe Fly
Moderna price target raised to $179 from $163 at Oppenheimer
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100